Income statement
USD
Annual
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 381K | 1M | 0 | 0 | 0 |
| Gross Profit | 381K | 1M | 0 | 0 | 0 |
| Operating Income | 250K | 607K | -77K | -12K | -10K |
| EBITDA | 250K | 1M | 4K | 0 | -10K |
| Net Income | 250K | 851K | -73K | -12K | -10K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 19, 2026
Coverage: 252 bars · Jun 23, 2025 → Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Western Sierra Resource Corporation (WSRC) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 19, 2026). Baseline metrics include revenue growth of -70.3%, EPS growth of -70.8%, a dividend yield of 0.0%. What stands out right now is revenue -70.3%, EPS -70.8%, free cash flow -2.7% with operating margin 65.6% and ROIC 0.3%. Valuation is more restrained than many high-expectation growth names at P/E 0.1 and price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WSRC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WSRC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WSRC Max Drawdown
-50.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WSRC and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$9.5K
+21.6% YoY
Free Cash Flow
-$901.9K
-10.7% YoY
Revenue Growth
-70.3%
EPS Growth
-70.8%
Gross Margin
100.0%
Net Margin
65.6%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 381K | 1M | 0 | 0 | 0 |
| Gross Profit | 381K | 1M | 0 | 0 | 0 |
| Operating Income | 250K | 607K | -77K | -12K | -10K |
| EBITDA | 250K | 1M | 4K | 0 | -10K |
| Net Income | 250K | 851K | -73K | -12K | -10K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 108 | 1K | 44 | 12K | 1K |
| Total Assets | 76M | 50M | 47M | 46M | 45M |
| Total Liabilities | 12M | 9M | 7M | 8M | 7M |
| Shareholder Equity | 64M | 42M | 41M | 38M | 38M |
| Total Debt | 10M | 6M | 7M | 8M | 7M |
| Net Debt | 10M | 6M | 7M | 8M | 7M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
10K
+21.6% YoY
Capital Expenditures
892K
-11.2% YoY
Free Cash Flow
902K
-10.7% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
65.6%
Net Margin
65.6%
ROE
0.5%
Debt / Equity
0.16x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.